Can stem-cell transplantation improve cardiac function in ischemic cardiomyopathy?

Kate Matthews

This article has no abstract so we have provided the first paragraph of the full text.

Congestive heart failure (CHF) is an important global health problem. This condition arises from myocardial dysfunction and prevents the heart from circulating sufficient blood to sustain the metabolic requirements of the body. Patel and co-workers hypothesized that autologous stem-cell transplantation to ischemic regions of the heart could regenerate cardiac myocytes and stimulate neovascularization, to restore myocardium viability and improve cardiac function, in patients undergoing off-pump coronary artery bypass grafting (OPCABG) for ischemic cardiomyopathy.

ARTICLE NAVIGATION - ARTICLE TOOLS

• Full text
• Download PDF
• Send to a friend
• PDA services
• Permissions
• Rights and permissions
• Order commercial reprints

ISSUE NAVIGATION - THIS ISSUE

• Table of Contents
• Previous article
• Next article